🇺🇸 FDA

Drug profile · INN

mercaptopurine

LOULLA

approved L01BB02
US status
approved
Patents linked
5
News articles
0

Quick answer

mercaptopurine (LOULLA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN mercaptopurine
Brand LOULLA
Route ORAL
Formulation SUSPENSION
ATC code L01BB02

Related patents

Search patents →

  1. US 10590137

    Mercaptopurine hemihydrate

    Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9375403

    Formulations of 6-mercaptopurine

    Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9180097

    Formulations of 6-mercaptopurine

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8653060

    Formulations of 6-mercaptopurine

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8188067

    Formulations of 6-mercaptopurine

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is mercaptopurine?

mercaptopurine (LOULLA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for mercaptopurine?

LOULLA is a marketed brand name for mercaptopurine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of mercaptopurine?

mercaptopurine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.